Dudediligence.

Medpace Holdings, Inc

MEDPNASDAQ · Services-Commercial Physical & Biological Research
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$533.3MSep ’24$536.6MDec ’24$558.6MMar ’25$603.3MJun ’25$659.9MSep ’25$708.5MDec ’25$706.6MMar ’26$707.3MJun ’26
Net income, by quarter
$96.4MSep ’24$117.0MDec ’24$114.6MMar ’25$90.3MJun ’25$111.1MSep ’25$135.1MDec ’25$123.9MMar ’26$121.4MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue$1.14B$1.46B$1.89B$2.11B$2.53B
Operating income$198.6M$278.7M$336.8M$446.9M$534.9M
Net income$181.8M$245.4M$282.8M$404.4M$451.1M
Operating cash flow$263.3M$388.1M$433.4M$608.8M$713.2M
Free cash flow$235.1M$351.2M$396.7M$572.3M$681.9M
Cash$461.3M$28.3M$245.4M$669.4M$497.0M
Debt$0.00$50.0M$0.00none on filenone on file
Shares outstanding36.0M31.1M30.8M30.6M28.4M